Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/DERMAPHARM-HOLDING-SE-40718509/attualita/Dermapharm-e-piu-ottimista-dopo-il-primo-semestre-il-prezzo-dell-azione-sale-44626095/?utm_source=whatsapp&utm_medium=social&utm_campaign=share